# A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants

> **NCT06523153** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Invivyd, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** VYD2311
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06523153
- **Lead sponsor:** Invivyd, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-28
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06523153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06523153, "A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06523153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*